[HTML][HTML] In vivo quantification of neurofibrillary tangles with [18F]MK-6240
TA Pascoal, M Shin, MS Kang, M Chamoun… - Alzheimer's research & …, 2018 - Springer
Background Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
In vivo quantification of neurofibrillary tangles with [18F] MK-6240
TA Pascoal, M Shin, MS Kang… - Alzheimer's …, 2018 - search.proquest.com
Background: Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
In vivo quantification of neurofibrillary tangles with [18F]MK-6240.
TA Pascoal, M Shin, MS Kang, M Chamoun… - … Research & Therapy, 2018 - europepmc.org
Background Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
[HTML][HTML] In vivo quantification of neurofibrillary tangles with [18F] MK-6240
TA Pascoal, M Shin, MS Kang… - Alzheimer's …, 2018 - alzres.biomedcentral.com
Imaging agents capable of quantifying the brain's tau aggregates will allow a more precise
staging of Alzheimer's disease (AD). The aim of the present study was to examine the in vitro …
staging of Alzheimer's disease (AD). The aim of the present study was to examine the in vitro …
In vivo quantification of neurofibrillary tangles with [18F] MK-6240
TA Pascoal, M Shin, MS Kang… - … research & therapy, 2018 - pubmed.ncbi.nlm.nih.gov
Background Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
[HTML][HTML] In vivo quantification of neurofibrillary tangles with [18F] MK-6240
TA Pascoal, M Shin, MS Kang… - … Research & Therapy, 2018 - ncbi.nlm.nih.gov
Background Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
In vivo quantification of neurofibrillary tangles with [18F]MK-6240.
TA Pascoal, M Shin, MS Kang… - Alzheimer's …, 2018 - search.ebscohost.com
Background: Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
In vivo quantification of neurofibrillary tangles with [18F] MK-6240
TA Pascoal, M Shin, MS Kang, M Chamoun… - … Research & Therapy, 2018 - go.gale.com
Background Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
[PDF][PDF] In vivo quantification of neurofibrillary tangles with [18 F] MK-6240
TA Pascoal, M Shin, MS Kang, M Chamoun… - 2018 - researchgate.net
Background: Imaging agents capable of quantifying the brain's tau aggregates will allow a
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
more precise staging of Alzheimer's disease (AD). The aim of the present study was to …
[引用][C] In vivo quantification of neurofibrillary tangles with [18F] MK-6240
TA Pascoal, M Shin, MS Kang, M Chamoun… - Alzheimer's Research & …, 2018 - cir.nii.ac.jp